2025年西交•通全球暑期学校（XJTISS）开课了！西安交通大学第二附属医院肝胆胰与肝移植外科蒋安主任医师，拟于2025年8月1-15日线上举办国际专题讲座。特邀欧洲、中亚顶尖肝病领域专家团队，沿着古丝绸之路，从长安开始一路向西，深度解析"一带一路"国家的肝病诊疗现状与技术差异，重点讲授病毒性肝炎、包虫病、肝脏肿瘤、移植、介入等治疗的前沿进展。课程通过腾讯会议全英文直播授课，为全球医学生提供跨境学术平台。参加全部课程后可以颁发证书，为你的求学、就业履历增色。

主讲人简介

蒋安教授（项目负责人），医学博士，博导，主任医师，现任肝胆胰与肝移植外科副主任。拥有美国匹兹堡大学博士后及台北研修经历。临床科研聚焦肝胆胃肠肿瘤、门脉高压、ERCP及肝移植。主持国家级项目2项、省级项目3项，获专利7项，发表论文40余篇。教学成果突出，开发胆石症诊疗教学软件并应用。担任西安医学会外科学分会主委等多项学术职务。获省科技进步二等奖、省科技新星、省高校科技成果一等奖。

吐尔干艾力·阿吉，新疆医科大学第一附属医院副院长、肝胆包虫病外科主任，兼消化血管外科中心副主任。任中国医师协会包虫病外科青委会主委。研修于日本京都大学及台湾高雄长庚肝移植中心，专注肝胆包虫病临床诊疗与学术体系建设。

Hind Ibrahim Bakor Fallata，沙特阿卜杜勒阿齐兹国王大学医学院教授、胃肠病学与肝病学顾问，FACP，持有沙特及阿拉伯委员会双重认证及医学教育硕士学位。专注慢性肝病（NAFLD、病毒性肝炎、自身免疫性肝病）及移植医学研究，发表论文60余篇。获2010年KAU最佳研究员奖及SASLT研究奖，致力于推动中东肝病诊疗与医学教育发展。

Alireza Shamsaeefar，伊朗设拉子医科大学外科副教授，阿布·阿里·西那器官移植中心专家。专注肝胆胰外科及肝胰多器官移植，研究涵盖移植后糖尿病机制、脂肪肝病理及免疫耐受策略。发表多篇高影响力论文于《Scientific Reports》等期刊，推动伊朗器官移植学科发展。

Georgios Germanidis，希腊塞萨洛尼基亚里士多德大学医学院教授、第一内科肝病与胃肠病科主任。聚焦肝细胞癌免疫微环境调控、免疫检查点抑制剂治疗策略及病毒性肝炎免疫应答机制研究。在《Gastroenterology》《Hepatology》等顶刊发表系列成果，现任《Hepatoma Research》编委。

Roberto Iezzi，意大利罗马圣心大学副教授、杰梅利大学医院介入放射科主任。专注肿瘤介入治疗（肝细胞癌/胆管癌转移瘤），精于TACE/RFA/SIRT等微创技术。发表SCI论文170余篇，任《Hepatoma Research》编委。

Markus Guba，德国慕尼黑大学医院肝癌中心主任、肝胆胰外科及移植外科负责人。专注肝脏恶性肿瘤外科治疗与肝移植免疫耐受机制，开创性探索mTOR抑制剂抗肿瘤作用。任Eurotransplant肝肠咨询委员会前主席，于《Nature Medicine》等顶刊发表高影响力论文，推动国际移植肿瘤学发展。

Jordi Gracia-Sancho，西班牙IDIBAPS肝脏血管生物学研究组负责人、CIBEREHD科学主任。聚焦肝窦内皮细胞在肝病及衰老中的分子机制研究，开创肝脏血管病理生理新领域。任《npj Gut & Liver》主编，获EASL新兴领袖奖及AASLD会士，推动肝病治疗策略发展。

报名方式：加入QQ群（群号：1051445887），具体登录信息以及相关链接，后续会发到QQ群中

咨询联络：蒋安邮箱：jiangan@xjtu.edu.cn

2025 XJTU Global Summer School

New Silk Road in Hepatology :Cross-Border Dialogue on Liver Diseases & Transplantation Research Across the Belt and Road

The Department of Hepatobiliary, Pancreatic and Transplant Surgery at Xi'an Jiao tong University's Second Affiliated Hospital will host an online International Lecture Series via Tencent Meeting from August 1-15, 2025. Esteemed liver disease specialists from Europe and Central Asia will trace the ancient Silk Road westward from Chang an (modern-day Xi'an), delivering in-depth analyses of hepatology practices and technological variations across Belt and Road countries. Lectures will comprehensively cover state-of-the-art advances in viral hepatitis, hydatid disease, liver tumors, transplantation, and interventional therapies, while providing a fully English academic platform for global medical students. A Certificate of Completion will be awarded to participants attending all sessions, enhancing academic credentials through this unique cross-border learning experience.

Speaker Profiles

Jiang An(Director): MD, PhD Supervisor, Chief Physician; Deputy Director of Hepatobiliary & Liver Transplant Surgery. US/China-trained expert in hepatobiliary oncology, portal hypertension, and transplantation. Leads 5 national/provincial projects, holds 7 patents with 40+ publications. Developed cholelithiasis teaching software. Awarded provincial science prizes and chairs Xi’an Surgical Association.

Tuerganaili Aji, VP of Xinjiang Medical University's First Affiliated Hospital, directs Hepatobiliary Hydatid Surgery and serves as Deputy Director of the Digestive Vascular Surgery Center. As Chair of the CMA Young Committee on Hydatid Surgery, he advances clinical and academic frameworks for hepatobiliary hydatidosis following specialized training at Kyoto University and Kaohsiung Chang Gung Liver Transplant Center.

Hind Ibrahim Bakor Fallata, Professor & Consultant in Gastroenterology & Hepatology at King Abdulaziz University, holds FACP credentials, dual Saudi/Arab Board certification, and a Medical Education Master’s. Specializing in chronic liver diseases and transplant medicine, she is recipient of KAU’s 2010 Best Researcher and SASLT awards, advancing hepatology and medical education in the Middle East.

Alireza Shamsaeefar, Associate Professor of Surgery at Shiraz University of Medical Sciences and specialist at Abu Ali Sina Organ Transplant Center, focuses on hepatobiliary-pancreatic surgery and multi-organ liver-pancreas transplantation. His research explores post-transplant diabetes mechanisms, fatty liver pathology, and immune tolerance strategies, with high-impact publications in journals includingScientific Reports, advancing Iran's transplant medicine discipline.

Georgios Germanidis, Chair of Hepatology & Gastroenterology at Aristotle University of Thessaloniki Medical School, focuses on HCC immune microenvironment regulation, immune checkpoint inhibitor therapies, and immune responses in viral hepatitis. A leading researcher with publications inGastroenterologyandHepatology, he serves on the editorial board ofHepatoma Research.

Roberto Iezzi, Associate Professor at Università Cattolica del Sacro Cuore and Director of Interventional Radiology at Gemelli University Hospital, specializes in interventional oncology for hepatic malignancies, with expertise in TACE, RFA, and SIRT techniques. Author of 170+ peer-reviewed publications and editorial board member ofHepatoma Research.

Markus Guba, Director of the Liver Cancer Center and Head of Hepatobiliary-Pancreatic & Transplant Surgery at Munich University Hospital, specializes in surgical oncology for hepatic malignancies and liver transplant immunotolerance. His pioneering research on mTOR inhibitors' antitumor effects, published inNature Medicine.

Jordi Gracia-Sancho, Head of the IDIBAPS Liver Vascular Biology Group and Scientific Director of CIBEREHD, pioneers research on liver sinusoidal endothelial cells in liver disease and aging, establishing new frontiers in hepatic vascular pathophysiology. Editor-in-Chief ofnpj Gut & Liverand recipient of the EASL Rising Star Award and AASLD Fellowship, he advances liver disease therapeutic strategies.

Registration:Join QQ Group: 1051445887 for login details

Contact:Prof. Jiang An Email: jiangan@xjtu.edu.cn